Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DE-127 (Atropine) in Pediatric Myopia (APPLE)
NCT03329638Phase 2Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Oct 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ryjusea in myopia, sponsored by Santen Pharmaceutical. Started Oct 2017; status: completed.
02
Drugs
Ryjusea
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03329638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329638.